Leggett & Platt - LEG Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Leggett & Platt in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" LEG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LEG, but not buy additional shares or sell existing shares.
View LEG analyst ratings or view top-rated stocks.

3 analysts have issued 1 year target prices for Leggett & Platt's shares. Their LEG share price forecasts range from $21.00 to $40.00. On average, they expect the company's stock price to reach $32.00 in the next twelve months. This suggests a possible upside of 0.4% from the stock's current price.
View analysts price targets for LEG or view top-rated stocks among Wall Street analysts.

Leggett & Platt's stock was trading at $32.23 at the beginning of 2023. Since then, LEG stock has decreased by 1.1% and is now trading at $31.88.
View the best growth stocks for 2023 here.

Leggett & Platt saw a decrease in short interest in the month of February. As of February 28th, there was short interest totaling 7,980,000 shares, a decrease of 5.8% from the February 13th total of 8,470,000 shares. Based on an average daily volume of 904,200 shares, the short-interest ratio is currently 8.8 days. Approximately 6.1% of the shares of the stock are short sold.
View Leggett & Platt's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023.
View our LEG earnings forecast.

Leggett & Platt, Incorporated (NYSE:LEG) posted its earnings results on Monday, February, 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.48 by $0.09. The company earned $1.20 billion during the quarter, compared to the consensus estimate of $1.24 billion. Leggett & Platt had a net margin of 6.02% and a trailing twelve-month return on equity of 19.09%. The company's revenue for the quarter was down 10.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.77 earnings per share.
Read the conference call transcript.

Leggett & Platt announced a quarterly dividend on Thursday, February 23rd. Investors of record on Wednesday, March 15th will be paid a dividend of $0.44 per share on Friday, April 14th. This represents a $1.76 annualized dividend and a yield of 5.52%. The ex-dividend date of this dividend is Tuesday, March 14th.
Read our dividend analysis for LEG.

ETFs with the largest weight of Leggett & Platt (NYSE:LEG) stock in their portfolio include Invesco High Yield Equity Dividend Achievers ETF (PEY), ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL), ProShares Russell US Dividend Growers ETF (TMDV), SPDR S&P Dividend ETF (SDY), Xtrackers S&P ESG Dividend Aristocrats ETF (SNPD), Victoryshares Dividend Accelerator ETF (VSDA), First Trust Consumer Discretionary AlphaDEX Fund (FXD) and Altrius Global Dividend ETF (DIVD).

Leggett & Platt (NYSE:LEG) pays an annual dividend of $1.76 per share and currently has a dividend yield of 5.73%. LEG has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 51 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 77.53%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, LEG will have a dividend payout ratio of 98.88% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for LEG.

Leggett & Platt updated its FY23 earnings guidance on Monday, February, 6th. The company provided EPS guidance of $1.50-$1.90 for the period, compared to the consensus EPS estimate of $2.06. The company issued revenue guidance of $4.8-$5.2 billion, compared to the consensus revenue estimate of $5.07 billion.

59 employees have rated Leggett & Platt Chief Executive Officer Karl G. Glassman on Glassdoor.com. Karl G. Glassman has an approval rating of 82% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Leggett & Platt investors own include AT&T (T), Exxon Mobil (XOM), Johnson & Johnson (JNJ), AbbVie (ABBV), Chevron (CVX), McDonald's (MCD), 3M (MMM), PepsiCo (PEP), Pfizer (PFE) and Walmart (WMT).

Leggett & Platt trades on the New York Stock Exchange (NYSE) under the ticker symbol "LEG."

Leggett & Platt's stock is owned by a variety of retail and institutional investors. Top institutional investors include Charles Schwab Investment Management Inc. (4.27%), Dimensional Fund Advisors LP (1.68%), Epoch Investment Partners Inc. (1.42%), Geode Capital Management LLC (1.37%), Morgan Stanley (1.30%) and ProShare Advisors LLC (0.78%). Insiders that own company stock include Joseph W Mcclanathan, Judy C Odom, Karl G Glassman, Kimberly Rutledge, Phoebe A Wood, Robert E Brunner, Scott S Douglas and Susan R Mccoy.
View institutional ownership trends.

Shares of LEG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LEG stock can currently be purchased for approximately $31.88.

Leggett & Platt (NYSE:LEG) has a market capitalization of $4.24 billion and generates $5.15 billion in revenue each year. The company earns $309.80 million in net income (profit) each year or $2.27 on an earnings per share basis.

The company employs 19,900 workers across the globe.

Leggett & Platt's mailing address is NO. 1 LEGGETT ROAD, CARTHAGE MO, 64836. The official website for the company is www.leggett.com. The company can be reached via phone at (417) 358-8131, via email at invest@leggett.com, or via fax at 417-358-8449.